Newsletter - All News

Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research

Category

Continent

From

To

Galderma starts Phase 2 trials of nemolizumab for...

Galderma starts Phase 2 trials of nemolizumab for...

Category : Clinical Trial Update 28 June 2025

Overview Galderma, a pure-play dermatology category leader, has announced the initiation of two n...

Pfizer’s Hympavzi shows good results in phase 3 BA...

Pfizer’s Hympavzi shows good results in phase 3 BA...

Category : Clinical Trial Update 27 June 2025

Overview Pfizer Inc. announced positive topline results from the phase 3 BASIS study (NCT03938792...

Aspire Biopharma completes Phase 1 enrollment for...

Aspire Biopharma completes Phase 1 enrollment for...

Category : Clinical Trial Update 27 June 2025

Overview Aspire Biopharma Holdings, Inc, developer of a multi-faceted patent-pending drug deliver...

Novartis completes acquisition of Regulus Therapeu...

Novartis completes acquisition of Regulus Therapeu...

Category : Licensing/Collaboration Deal 27 June 2025

Overview Novartis today announced that it has successfully completed its acquisition of Regulus T...

Lipocine Announces First Patient Dosed in Phase 3...

Lipocine Announces First Patient Dosed in Phase 3...

Category : Clinical Trial Update 27 June 2025

Overview Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary tec...

‹
1
2

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.